Votis is a groundbreaking brand in the field of subdermal imaging technologies. Their innovative product is designed to help screen, stage, and monitor the diabetic foot safely. With a focus on providing clinical decision support for the diagnosis and monitoring of diabetic foot syndrome and related conditions, Votis offers a non-invasive and ionizing-radiation-free solution.

Chronic limb-threatening ischemia (CLTI) is a critical condition of peripheral artery disease (PAD), affecting millions of people worldwide. Votis addresses this by accompanying PAD/CLTI patients throughout their journey. Their comprehensive approach includes the PedCheck™, which screens for peripheral artery disease, the PedStage™ for assessing blood and oxygen flow, and the PedFlo™ for real-time blood flow assessment during surgical procedures.

Votis distinguishes itself with a portable, inexpensive, and easy-to-use device that employs single-use consumable patches and a small, lightweight unit. With solid IP protection and an impressive team of experts, including renowned medical professionals and experienced industry veterans, Votis is committed to delivering cutting-edge technology and transforming diabetic foot care. To keep up with their latest developments, clinical trials, and news, visit the Votis website or get in touch with their team today